| Phase 1 | 1 | |
| Phase 1/2 | 1 | |
| Phase 2 | 2 | |
| Phase 3 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07128550 | A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not… | Viral Hepatitis | Active, Not Recruiting | 2026-07-13 |
| NCT06903338 | A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV Infection | Viral Hepatitis | Active, Not Recruiting | 2026-04-08 |
| Phase 2 | ||||
| NCT05461170 | SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection. | Hepatitis D, Chronic | Active, Not Recruiting | 2026-06-26 |
| NCT07142811 | A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infection | Viral Hepatitis | Active, Not Recruiting | 2026-01-16 |
| Phase 1/2 | ||||
| NCT05356741 | To Access the Safety and Effects of Intravenous Administration of VIR-5818 Alone and in… | Locally Advanced or Metastatic HER2-Expressing Cancers | Recruiting | 2026-08-19 |
| Phase 1 | ||||
| NCT06960395 | Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants… | Solid Tumor Malignancies | Recruiting | 2026-04-13 |